We used microarrays to perform systematic profiling of human microRNAs in plasma from nasopharyngeal carcinoma (NPC) patients to find potential biomarkers. By comparing the plasma microRNA profiles of
Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a smal
Note: GP-Gene pairs, P1-percentage of No. of gene pairs in total pairs, P2-percentage of the number of genes with normality in No. of GP. Shapiro-wilk testing with a cut-off values of 0.01. P-values <